Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. - Archive ouverte HAL Access content directly
Journal Articles Amer. J. Vet. Res. Year : 2010

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.

Hahn K.A.
  • Function : Author
Legendre A.M.
  • Function : Author
Shaw N.G.
  • Function : Author
B. Phillips
  • Function : Author
Ogilvie G.K.
  • Function : Author
Prescott D.M.
  • Function : Author
Atwater S.W.
  • Function : Author
Carreras J.K.
  • Function : Author
Lana S.E.
  • Function : Author
T. Ladue
  • Function : Author
A. Usk
  • Function : Author
Kinet J.P.
  • Function : Author
Pascal Dubreuil
  • Function : Author
A. Moussy
  • Function : Author
O. Hermine
No file

Dates and versions

hal-00539582 , version 1 (24-11-2010)

Identifiers

  • HAL Id : hal-00539582 , version 1

Cite

Hahn K.A., Legendre A.M., Shaw N.G., B. Phillips, Ogilvie G.K., et al.. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.. Amer. J. Vet. Res., 2010, 71, pp.1354-1361. ⟨hal-00539582⟩

Collections

CNRS
16 View
0 Download

Share

Gmail Facebook X LinkedIn More